Nelarabine- A New Purine Analog in the Treatment of Hematologic Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|1|3|185-192

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.1, Iss.3, 2006-09, pp. : 185-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FISH panels for hematologic malignancies

By  

Cytogenetic and Genome Research, Vol. 118, Iss. 2-4, 2007-11 ,pp. : 284-296

Karger

Access to resources Recommend Favorite

Recombinant Urate Oxidase (Rasburicase) for the Prevention and Treatment of Tumor Lysis Syndrome in Patients with Hematologic Malignancies

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 35-38

Karger

Access to resources Recommend Favorite

Decrease in Vancomycin-Resistant Enterococcus Colonization After Extensive Renovation of a Unit Dedicated to the Treatment of Hematologic Malignancies and Hematopoietic Stem-Cell Transplantation

By  

Infection Control & Hospital Epidemiology, Vol. 38, Iss. 9, 2017-07 ,pp. : 1055-1061

Cambridge University Press

Access to resources Recommend Favorite

Plasma concentration of micafungin in patients with hematologic malignancies

By Nakagawa Yasunori   Ichii Yoko   Saeki Yasuhiro   Kodaka Masanobu   Suzuki Kenshi   Kishino Satoshi  

Journal of Infection and Chemotherapy, Vol. 13, Iss. 1, 2007-02 ,pp. : 39-45

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Protein Kinase C-Alpha in Hematologic Malignancies

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 1-8

Karger

Access to resources Recommend Favorite